openPR Logo
Press release

Increasing Incidence Of Thyroid Diseases Driving Market Growth: A Key Factor Shaping the Future of the Tepezza Market in 2025

03-28-2025 09:00 AM CET | Health & Medicine

Press release from: The Business Research Company

Tepezza

Tepezza

Which drivers are expected to have the greatest impact on the over the tepezza market's growth?
The increasing incidence of thyroid diseases is expected to fuel the growth of the Tepezza market. Thyroid diseases are rising due to improvements in diagnostic techniques, allowing for earlier detection. Tepezza treats thyroid eye disease by reducing inflammation and swelling around the eyes. For example, in July 2022, the NIH projected 44,000 new cases of thyroid cancer in the U.S. in 2022. Therefore, the increasing incidence of thyroid diseases is anticipated to promote the growth of the Tepezza market.

Get Your Tepezza Market Report Here:
https://www.thebusinessresearchcompany.com/report/tepezza-global-market-report

What is the future CAGR of the tepezza market, and how will it impact industry expansion?
The Tepezza market size has shown XX (HCAGR) in recent years. It will rise from $XX million in 2024 to $XX million in 2025, at a compound annual growth rate (CAGR) of XX%. The growth in the historic period is attributed to the increasing prevalence of thyroid eye disease (TED), FDA approval for TED treatment, limited treatment options for TED, high unmet needs for effective therapies, advances in biologic drug development, and growing awareness and diagnosis of TED.

The Tepezza market size is expected to grow significantly in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to a growing aging population, expansion into new geographical markets, increasing incidence of thyroid diseases, advancements in personalized medicine, and growing adoption of biologic therapies. Major trends include a shift toward home-based care, development of alternative administration methods, a rise in combination therapies for TED, increasing focus on precision medicine, and integration of AI in treatment planning.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20365&type=smp

What are the most significant trends transforming the tepezza market today?
A key development in the tepezza (teprotumumab-trbw) market is the pursuit of regulatory clearances to extend its use beyond Thyroid Eye Disease (TED). Regulatory approvals are formal permissions given by health authorities that validate a drug's safety, effectiveness, and quality for specific medical purposes. For example, in April 2023, Horizon Therapeutics plc, a biotech company based in Ireland, stated that the FDA had given their approval for an update to TEPEZZA's indication wording, permitting its usage in TED patients regardless of the disease's activity or duration. This major modification improves all eligible TED patients' access to treatment since TEPEZZA is the only FDA-sanctioned drug specifically intended for this condition. The endorsement is supported by information from a Phase 4 clinical study that shows TEPEZZA's effectiveness in reducing eye bulging in patients with prolonged TED. Tim Walbert, CEO of Horizon, underscored that this modification aims at enhancing prompt access to treatment, thus positively impacting patient outcomes.

Which key market segments comprise the tepezza market and drive its revenue growth?
The tepezza market covered in this report is segmented -

1) By Clinical Indication: Thyroid Eye Disease (TED); Orbital Inflammatory Diseases; Inflammatory Ocular Conditions
2) By Route Of Administration: Intravenous; Subcutaneous
3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies
4) By End User: Adult; Geriatric

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20365

What regions are at the forefront of tepezza market expansion?
North America was the largest region in the tepezza market in 2024. The regions covered in the tepezza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the tepezza market?
Major companies operating in the tepezza market are Amgen Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20365&type=smp

What Is Covered In The Tepezza Global Market Report?

•Market Size Forecast: Examine the tepezza market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the tepezza market for a structured understanding.
•Key Players Overview: Analyze major players in the tepezza market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the tepezza market.
•Segment Contributions: Evaluate how different segments drive overall growth in the tepezza market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the tepezza market.
•Industry Challenges: Identify potential risks and obstacles affecting the tepezza market.
•Competitive Landscape: Review strategic developments in the tepezza market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Increasing Incidence Of Thyroid Diseases Driving Market Growth: A Key Factor Shaping the Future of the Tepezza Market in 2025 here

News-ID: 3944128 • Views:

More Releases from The Business Research Company

Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additive Manufacturing Cell Market
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory. Projected Expansion of the Wire Arc Additive Manufacturing Cell Market The wire arc additive manufacturing cell
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for Arthritis Market Until 2029
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry. Projected Market Growth and Size of
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Development Service Market
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future. Projected Expansion and Market Size of
Competitive Landscape: Leading Companies and New Entrants in the Transient Elastography Market
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry. Projected Market Value and Growth of the Transient Elastography Market The transient elastography market is

All 5 Releases


More Releases for Tepezza

Thyroid Eye Disease Market Poised to Grow at 8.5% CAGR, Reaching USD 3.0 Billion …
Introduction Thyroid Eye Disease (TED), also known as thyroid-associated ophthalmopathy or orbitopathy, is an autoimmune condition that affects the tissues around the eyes. Closely linked to Graves' disease, TED is characterized by inflammation, swelling, double vision, and in severe cases, sight-threatening complications due to optic nerve compression. The disorder has a profound impact on quality of life, requiring multidisciplinary management by endocrinologists and ophthalmologists. The global Thyroid Eye Disease (TED) Market is
Graves' Disease Market New Product Development & Latest Trends
Introduction Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overproduction of thyroid hormones, through antibodies that stimulate the thyroid gland. It is among the most common thyroid-related autoimmune conditions, disproportionately affecting women between 30-60 years of age. Beyond metabolic complications such as weight loss, heat intolerance, and palpitations, Graves' disease can cause thyroid eye disease (TED), which impairs vision and quality of life. For decades, treatment has relied on antithyroid
Tepezza Market Report 2025-2034: Industry Overview, Drivers, And Forecast Analys …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. What Is the Current Tepezza Market Size and Its Estimated Growth Rate? In recent years, the market size for Tepezza has experienced an XX (HCAGR). There's an expected growth from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of XX%. Several factors can be
Transforming the Tepezza Market in 2025: Increasing Incidence Of Thyroid Disease …
How Will the Tepezza Market Grow, and What Is the Projected Market Size?_x000D_ Over recent years, the market size for Tepezza has risen by $XX (CAGR). It is projected to see an increase from $XX million in 2024 to $XX million in 2025, boasting a compound annual growth rate (CAGR) of $XX%. This historical growth can be credited to factors such as the escalating rates of thyroid eye disease, FDA approval
Graves Ophthalmopathy Market to Expand Significantly by 2034, States DelveInsigh …
The Key Graves Ophthalmopathy Companies in the market include - Immunovant Sciences GmbH, Horizon Pharma USA, Inc., Viridian Therapeutics, Inc., Tourmaline Bio, Inc., ACELYRIN Inc., Hoffmann-La Roche, Horizon Therapeutics USA, Inc., Lassen Therapeutics Inc., Novartis, Sling Therapeutics, Inc., Lassen Therapeutics, and others. The Graves Ophthalmopathy market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Graves Ophthalmopathy pipeline products will
Graves' Ophthalmopathy Therapeutics Market Size was ~USD 2,600 million in 2023, …
DelveInsight's "Graves Ophthalmopathy Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Graves Ophthalmopathy, historical and forecasted epidemiology as well as the Graves Ophthalmopathy market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan. Discover Key Insights into the Graves Ophthalmopathy Market with DelveInsight's In-Depth Report @ Graves Ophthalmopathy Market Size- https://www.delveinsight.com/sample-request/graves-ophthalmopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from